Leveljump Healthcare (TSXV: JUMP) is looking to expand its current portfolio. The company last night announced a minority investment in a firm focused on providing a nationwide radiology collaboration service across Canada.
Leveljump has taken a 14.6% stake in Real Time Medical Inc, which it has acquired via the issuance of common shares. A total of 2.5 million units were issued in exchange for the investment at a price of $0.22 per unit, valuing the stake at roughly $549,000.
Real Time Medical is said to be focused providing a radiology collaboration service across Canada, providing workload balancing, workflow orchestration, and diagnostics operations software to its clients. The network has been in place since 2008, and was originally founded by three radiologists. The firm claims to conduct business with over 50 hospitals across Canada.
“We are very excited about this investment and believe that with Real Time’s teleradiology operations and servicing in multiple provinces across Canada, that there is a natural complement to our core CTS operations,” commented Mitch Geisler, CEO of Leveljump, on the investment.
The 14.6% stake in the company was acquired via a tender, where the company looked to take up to a 19.9% stake in the private operator via the purchase of shares from outstanding holders. Units issued are said to include one common share and one common share purchase warrant, with each warrant valid until December 31, 2023. Warrants have an exercise price of $0.35 per share.
Leveljump Healthcare last traded at $0.165 on the TSX Venture.
FULL DISCLOSURE: Leveljump Healthcare Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Leveljump Healthcare Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.